Cryptococcal Meningitis in AIDS Patients A Pilot Study of Fluconazole Therapy in 52 Patients

  • B. Dupont
  • I. Hilmarsdottir
  • A. Datry
  • M. Gentilini
  • P. Dellamonica
  • E. Bernard
  • S. Lefort
  • J. Frottier
  • P. Choutet
  • J. L. Vilde
  • The French study group on fluconazole in cryptococcal meningitis in AIDS patients

Summary

Cryptococcal meningitis in AIDS patients is liable to relapse and carries a high mortality rate. Standard treatment with amphotericin B and 5-fluorocytosine is limited by toxic effects. In the present study 64 AIDS patients with cryptococcal meningitis were admitted to a multicentre trial of fluconazole given either orally or intravenously. After a loading dose of 400 mg, two dosage regimens were adopted: 150–200 mg, or 400 mg daily for at least 45–60 days; subsequent maintenance therapy was 100 or 200 mg daily for both groups. Forty seven of the 52 evaluable patients were alive and improved or asymptomatic at day 60 and respectively 7 of 14 and 27 of 31 of those on 200 mg or 400 mg per day had negative cultures of the cerebrospinal fluid. Relapse rate under maintenance therapy was 23%. Fluconazole was well tolerated and free from severe side effects. These results merit further study of fluconazole, either alone or in combination.

Keywords

Meningitis Candida Amphotericin Rifampicin Encephalitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bennett, J.E., Dismukes, W.E., Duma, T.R. et al., 1975, A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis, N. Engl. J. Med., 301:126.CrossRefGoogle Scholar
  2. Byrne, W.R., and Wajszczuk, C.P., 1988, Cryptococcal meningitis in AIDS: successful treatment with fluconazole after failure of amphotericin B, Ann. Intern. Med., 108:384.PubMedGoogle Scholar
  3. Chuck, S.L., and Sande, M.A., 1989, Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome, N. Engl. J. Med., 21:794.CrossRefGoogle Scholar
  4. Dismukes, W.E., 1988, Cryptococcal meningitis in patients with AIDS, J. Infect. Dis., 157:624.PubMedCrossRefGoogle Scholar
  5. Dismukes, W., Cloud, G., Thompson, S., Sugar, A. et al., NIAID mycoses study group, 1989, Fluconazole versus amphotericin B therapy of acute cryptococcal meningitis, Abstract No. 1065, ICAAC.Google Scholar
  6. Dupont, B., and Drouhet, E., 1987, Cryptococcal meningitis and fluconazole, Ann. Intern. Med., 106:778.PubMedGoogle Scholar
  7. Eng, R.H.K., Bishburg, E., Smith, S.M., and Kapila, R., 1986, Cryptococcal infections in patients with acquired immune deficiency syndrome, Am. J. Med., 81:19.PubMedCrossRefGoogle Scholar
  8. Gans de, J., Eeftinck Schattenkerk, J.K.M., and Ketel, V.R.J., 1988, Itraconazole as maintenance treatment for crytococcal meningitis in the acquired immune deficiency syndrome, Br. Med. J., 296.Google Scholar
  9. Graybill, J.R., 1987, Fluconazole efficacy in animal models of mycotic diseases, in: “Recent Trends in the discovery, Development and Evaluation of Antifungal Agents”, R.A. Fromtling, ed., Prous Science, Barcelona.Google Scholar
  10. Katlama, C., Leport, C., Matheron, S. et al., 1984, Acquired immunodeficiency syndrome in Africans, Ann. Soc. Belge Med. Trop., 64:379.Google Scholar
  11. Kovacs, J.A., Kowacs, A.A., Polis, M. et al., 1985, Cryptococcosis in the acquired immunodeficiency syndrome, Ann. Intern. Med., 103:533.PubMedGoogle Scholar
  12. Larsen, R.A., and Leal, M.E., 1989, Fluconazole compared to amphotericin B as treatment of cryptococcal meningitis, Abstract No. 10 62, ICAAC.Google Scholar
  13. Perfect, J.R., Savani, D.V., and Durack, D.T., 1986, Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits, Antimicrob. Agents Chemother., 29:579.PubMedGoogle Scholar
  14. Piot, P., Taelman, H., Rapita, B.M. et al., 1984, Acquired immunodeficiency syndrome in a heterosexual population in Zaire, Lancet, 2:65.PubMedCrossRefGoogle Scholar
  15. Stern, J.J., Hartman, B.J., Sharkey, P., Rowland, V., Squires, K.E., Murray, H.W., and Graybill, R., 1988, Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients, Am. J. Med., 85:477.PubMedCrossRefGoogle Scholar
  16. Sugar, A.M., and Saunders, C., 1988, Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome, Am. J. Med., 85:481.PubMedCrossRefGoogle Scholar
  17. Van Cutsem, J., Van Gerven, F., and Janssen, P.A.J., 1987, The in vitro and in vivo antifungal activity of itraconazole, in: “Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents”, R.A. Fromtling, ed., Prous Science, Barcelona.Google Scholar
  18. Van ‘t Wout, J.W., de Graeff-Meeder, E.R., Paul, L.C., Kuis, W., and Van Furth, R., 1988, Treatment of two cases of cryptococcal meningitis with fluconazole, Scand. J. Infect. Dis., 20:193.CrossRefGoogle Scholar
  19. Viviani, M.A., Tortorana, A.M., and Giani, P.C., 1987, Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome, Ann. Intern. Med., 106.Google Scholar
  20. Zuger, A., Lonie, E., Molzmann, R.S., Simberkoff, M.S., and Rahal, J.J., 1988, Cryptococcal disease in patients with the acquired immunodeficiency syndrome, Ann. Intern. Med., 104:234.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • B. Dupont
    • 1
  • I. Hilmarsdottir
  • A. Datry
  • M. Gentilini
  • P. Dellamonica
  • E. Bernard
  • S. Lefort
  • J. Frottier
  • P. Choutet
  • J. L. Vilde
  • The French study group on fluconazole in cryptococcal meningitis in AIDS patients
  1. 1.Pasteur InstituteHospital and Mycology UnitParisFrance

Personalised recommendations